Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Laura J H Milgram"'
Autor:
Mary E. Teresi, Mark R. Weatherly, Kathleen A. Hilliard, Janice L. Launspach, Richard C. Ahrens, Moira L. Aitken, Nael A. McCarty, Warren E. Regelmann, Michael W. Konstan, Thomas A. Standaert, Cynthia Tuthill, Thomas J. Kelley, Laura J H Milgram
Publikováno v:
Pediatric Pulmonology. 33:90-98
CPX (8-cyclopentyl-1,3-dipropylxanthine) is a novel compound currently under development as a potential treatment for cystic fibrosis (CF). The drug has been shown to increase chloride efflux and CFTR trafficking in vitro in CF airway cells. This pha
Autor:
Kathleen A. Hilliard, Moira L. Aitken, Michael W. Konstan, Mary E. Teresi, Mark R. Weatherly, Richard C. Ahrens, Thomas A. Standaert, Laura J H Milgram, Thomas J. Kelley, Nael A. McCarty, Janice L. Launspach, Seung-Ho Han
Publikováno v:
Pediatric Pulmonology. 33:142-150
One of the goals of current research in cystic fibrosis (CF) is to develop treatments that correct or compensate for defects in function of the cystic fibrosis transmembrane regulator (CFTR) gene. The use of outcome measures that assess CFTR function
Autor:
Laura J H Milgram
Publikováno v:
Annals of the American Thoracic Society. 11(6)
The United States Food and Drug Administration recently considered a policy to transfer inhaled short-acting bronchodilators to over-the-counter status if conditions of safe use can be established. The American Thoracic Society filed a comment in opp
Publikováno v:
Proceedings of the National Academy of Sciences. 94:2604-2608
The gene causing cystic fibrosis (CF) encodes the CF transmembrane conductance regulator (CFTR), a cAMP-regulated chloride channel. Mutations in this gene result in reduced transepithelial chloride permeability across tissues affected in CF. Conseque
Autor:
Lisa LaVange, Jean M. Engels, Bruce C. Marshall, Amy E. Schaberg, George Z. Retsch-Bogart, Bonnie W. Ramsey, Cori L. Daines, Judy Williams, Jo Ann Gorden, Pamela L. Zeitlin, Carlos Milla, Ronald L. Gibson, Dave Mathews, Robin R. Deterding, Laura J H Milgram
Publikováno v:
Pediatric pulmonology. 39(4)
Denufosol tetrasodium (INS37217) is a selective P2Y(2) agonist that stimulates ciliary beat frequency and Cl(-) secretion in normal and cystic fibrosis (CF) airway epithelia, and is being investigated as an inhaled treatment for CF. The Cl(-) secreto
Autor:
Carla Foy, Peadar G. Noone, Pierre Yves Berclaz, Michael W. Konstan, Louis J. Boitano, Julia Emerson, Thomas A. Standaert, Michael R Knowles, Keith Hammond, Lois Brass, Pamela L. Zeitlin, Zoe Davies, Laura J H Milgram, Janice Hunter
Publikováno v:
Pediatric pulmonology. 37(5)
Patients with cystic fibrosis (CF) can be discriminated from healthy subjects by measurement of the nasal potential difference, which has become a useful outcome measure for therapies directed toward correcting defective electrolyte transport in CF.
A multicenter study of the effect of solution temperature on nasal potential difference measurements
Autor:
Carla Foy, Michael P. Boyle, Michael R. Knowles, Thomas A. Standaert, Laura J H Milgram, Marie Diener-West, Pamela L. Zeitlin
Publikováno v:
Chest. 124(2)
Nasal potential difference (PD) measurement quantifies the abnormal sodium and chloride transport that is characteristic of cystic fibrosis (CF) and has gained acceptance as both a diagnostic tool and outcome measure for new CF therapies. Because sma
Autor:
Don Kellerman, Peadar G. Noone, Ronald L. Gibson, Pamela L. Zeitlin, W. Craig Johnson, Jean Mundahl, David M. Rodman, Bonnie W. Ramsey, Moira L. Aitken, Michael P. Boyle, Michael W. Konstan, Laura J H Milgram, Judy Williams-Warren, Mark Dovey, George Retsch-Bogort, Robert W. Wilmott, Nicole Hamblett, Frank J. Accurso
Publikováno v:
Pediatric pulmonology. 32(2)
Cystic fibrosis (CF) is characterized by defective cystic fibrosis transmembrane regulator (CFTR) expression and function, associated with abnormal ion transport and mucociliary clearance, and clinical lung disease. Triphosphate nucleotides such as u
Autor:
Jennifer M. Payne, Osman Muhammad, Mark J. Cooper, Tomasz Kowalczyk, Robert C. Moen, Assem G. Ziady, Pamela B. Davis, Michael W. Konstan, Kathleen A. Hilliard, Susannah L. Hyatt, Jeffrey S. Wagener, Laura J H Milgram, Tamara L. Fink, Christopher R. Gedeon, Sharon M. Oette, Robert C. Stern
Publikováno v:
Human Gene Therapy. :041210060115001
A double-blind, dose escalation gene transfer trial was conducted in subjects with cystic fibrosis (CF), among whom placebo (saline) or compacted DNA was superfused onto the inferior turbinate of the right or left nostril. The vector consisted of sin